Your browser doesn't support javascript.
loading
The Impact of 68Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine Tumours.
Cuthbertson, Daniel J; Barriuso, Jorge; Lamarca, Angela; Manoharan, Prakash; Westwood, Thomas; Jaffa, Matthew; Fenwick, Stephen W; Nuttall, Christina; Lalloo, Fiona; Prachalias, Andreas; Pizanias, Michail; Wieshmann, Hulya; McNamara, Mairead G; Hubner, Richard; Srirajaskanthan, Raj; Vivian, Gillian; Ramage, John; Weickert, Martin O; Pritchard, D Mark; Vinjamuri, Sobhan; Valle, Juan; Yip, Vincent S.
Affiliation
  • Cuthbertson DJ; Liverpool University Hospitals NHS Foundation Trust, ENETS Centre of Excellence, Liverpool, United Kingdom.
  • Barriuso J; Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom.
  • Lamarca A; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
  • Manoharan P; Department of Medical Oncology, The Christie NHS Foundation Trust, ENETS Centre of Excellence, Manchester, United Kingdom.
  • Westwood T; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
  • Jaffa M; Department of Medical Oncology, The Christie NHS Foundation Trust, ENETS Centre of Excellence, Manchester, United Kingdom.
  • Fenwick SW; Department of Radiology and Nuclear Medicine, The Christie NHS Foundation Trust ENETS Centre of Excellence, Manchester, United Kingdom.
  • Nuttall C; Department of Radiology and Nuclear Medicine, The Christie NHS Foundation Trust ENETS Centre of Excellence, Manchester, United Kingdom.
  • Lalloo F; Liverpool University Hospitals NHS Foundation Trust, ENETS Centre of Excellence, Liverpool, United Kingdom.
  • Prachalias A; Liverpool University Hospitals NHS Foundation Trust, ENETS Centre of Excellence, Liverpool, United Kingdom.
  • Pizanias M; Department of Medical Oncology, The Christie NHS Foundation Trust, ENETS Centre of Excellence, Manchester, United Kingdom.
  • Wieshmann H; Department of Clinical Genetics, Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Saint Mary's Hospital, Manchester, United Kingdom.
  • McNamara MG; Institute of Liver Studies, Kings College Hospital, London, United Kingdom.
  • Hubner R; Institute of Liver Studies, Kings College Hospital, London, United Kingdom.
  • Srirajaskanthan R; Liverpool University Hospitals NHS Foundation Trust, ENETS Centre of Excellence, Liverpool, United Kingdom.
  • Vivian G; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
  • Ramage J; Department of Medical Oncology, The Christie NHS Foundation Trust, ENETS Centre of Excellence, Manchester, United Kingdom.
  • Weickert MO; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
  • Pritchard DM; Department of Medical Oncology, The Christie NHS Foundation Trust, ENETS Centre of Excellence, Manchester, United Kingdom.
  • Vinjamuri S; Neuroendocrine Tumour Unit, KHP ENETS Centre of Excellence, Institute of Liver Studies, Kings College Hospital, London, United Kingdom.
  • Valle J; Neuroendocrine Tumour Unit, KHP ENETS Centre of Excellence, Institute of Liver Studies, Kings College Hospital, London, United Kingdom.
  • Yip VS; Neuroendocrine Tumour Unit, KHP ENETS Centre of Excellence, Institute of Liver Studies, Kings College Hospital, London, United Kingdom.
Front Endocrinol (Lausanne) ; 12: 654975, 2021.
Article in En | MEDLINE | ID: mdl-34163434

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Neuroendocrine Tumors / Radiopharmaceuticals / Positron-Emission Tomography / Gallium Radioisotopes / Heterocyclic Compounds, 1-Ring Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Front Endocrinol (Lausanne) Year: 2021 Document type: Article Affiliation country: Reino Unido Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Neuroendocrine Tumors / Radiopharmaceuticals / Positron-Emission Tomography / Gallium Radioisotopes / Heterocyclic Compounds, 1-Ring Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Front Endocrinol (Lausanne) Year: 2021 Document type: Article Affiliation country: Reino Unido Country of publication: Suiza